Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2005 Mar 8;19(2):80–83. doi: 10.1002/jcla.20056

Relationship between renal anemia and prognostic stages of IgA nephropathy

Seiki Aruga 1, Tomohide Horiuchi 1, Ichiyu Shou 1, Kyouichi Tashiro 1, Atsushi Kurusu 1, Mitsumine Fukui 1, Satoshi Horikoshi 1, Yasuhiko Tomino 1,✉
PMCID: PMC6807749  PMID: 15756704

The content is available as a PDF (80.7 KB).

REFERENCES

  • 1. Sakai H, Abe K, Kobayashi Y, et al. Clinical guidelines of IgA nephropathy. Jpn J Nephrol 1995;37:417–421. [PubMed] [Google Scholar]
  • 2. Tomino Y, Sakai H. Clinical guidelines of IgA nephropathy in Japan, 2nd version. Clin Exp Nephrol 2003;7:93–97. [DOI] [PubMed] [Google Scholar]
  • 3. Kurusu A, Suzuki Y, Horikoshi S, Shirato I, Tomino Y. Relationship between mast cells in the tubulointerstitum and prognosis of patients with IgA nephropathy. Nephron 2001;89:391–397. [DOI] [PubMed] [Google Scholar]
  • 4. Lacombe C, Da Silva JL, Bruneval P, et al. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988;81:620–623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin‐producing cells using transgenic mice. Kidney Int 1993;44:1149–1162. [DOI] [PubMed] [Google Scholar]
  • 6. Tan CC, Tan LH, Eckardt KU. Erythropoietin production in rats with post‐ischemic acute renal failure. Kidney Int 1996;50:1958–1964. [DOI] [PubMed] [Google Scholar]
  • 7. Maxwell PH, Ferguson DJ, Nicholls LG, Johnson MH, Ratcliffe PJ. The interstitial response to renal injury: fibroblast‐like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 1997;52:715–724. [DOI] [PubMed] [Google Scholar]
  • 8. Kaneo K, Matsui K, Moriuma H, et al. Fundamental evaluation of the radioimmunoassay kit for erythropoietin (EPO) [in Japanese]. Igakuto Yakugaku 1989;21:659–664. [Google Scholar]
  • 9. Zweig MH, Campbell G. Receiver‐operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561–577. [PubMed] [Google Scholar]
  • 10. Spivac J. The mechanism of action of erythropoietin. Int J Cell Cloning 1986;4:139–166. [DOI] [PubMed] [Google Scholar]
  • 11. Erslev AJ, Besarab A. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 1997;51:622–630. [DOI] [PubMed] [Google Scholar]
  • 12. Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997;75:426–430. [DOI] [PubMed] [Google Scholar]
  • 13. Nielsen OJ, Thaysen JH. Erythropoietin deficiency in acute tubular necrosis. J Intern Med 1990;227:373–380. [DOI] [PubMed] [Google Scholar]
  • 14. Thaysen JH, Nielsen OJ, Brandi L, Szpirt W. Erythropoietin deficiency in acute crescentic glomerulonephritis and in total bilateral renal cortical necrosis. J Intern Med 1991;229:363–369. [DOI] [PubMed] [Google Scholar]
  • 15. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12:5447–5454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Wang GL, Smenzaa GL. General involvement of hypoxia inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993;90:4304–4308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia‐induced erythropoietin production. Blood 1992;79:1987–1994. [PubMed] [Google Scholar]
  • 18. Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1991;50:301–308. [DOI] [PubMed] [Google Scholar]
  • 19. Schena FP, Gesualdo L, Grandaliano G, Montinard V. Progression of renal damage in human glomerulonephritis: is there sleight of hand in winning the game? Kidney Int 1997;52:1439–1457. [DOI] [PubMed] [Google Scholar]
  • 20. Machiguchi T, Yoshida H, Yonemoto S, et al. Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N‐acetyl‐ß‐D‐glucosaminidase. Nephrol Dial Transplant 1999;14:635–640. [DOI] [PubMed] [Google Scholar]
  • 21. Wide L, Bengtsson C, Birgegard G. Circadian rhythm of erythropoietin in human serum. Br J Hematol 1989;72:85–90. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES